1-3 of 3
Marinus H. van Oers
Close
Sort by
Journal Articles

Interim Analysis Of Dose-Escalation Stage Of a Phase 1b Study Evaluating Safety and Pharmacology Of GS-9820, a Second-Generation, Selective, PI3Kd-Inhibitor in Recurrent Lymphoid Malignancies

Arnon P. Kater, MD PhD, Sanne H. Tonino, MD, PhD, Marie Jose Kersten, MD, PhD, Anton Hagenbeek, MD, PhD, Marjolein Spiering, Msc, Marinus H van Oers, MD PhD, Yan Xin, PhD, Srinivasan Ramanathan, PhD, Maria Aiello, MA, Susie Jun, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2881.
https://doi.org/10.1182/blood.V122.21.2881.2881
Published: 2013
Journal Articles

A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma

Henk M. Lokhorst, Bronno van der Holt, Sonja Zweegman, Edo Vellenga, Sandra Croockewit, Marinus H. van Oers, Peter von dem Borne, Pierre Wijermans, Ron Schaafsma, Okke de Weerdt, Shulamiet Wittebol, Michel Delforge, Henriëtte Berenschot, Gerard M. Bos, Kon-Siong G. Jie, Harm Sinnige, Marinus van Marwijk-Kooy, Peter Joosten, Monique C. Minnema, Rianne van Ammerlaan, Pieter Sonneveld, for Dutch-Belgian Hemato-Oncology Group (HOVON)
Journal: Blood
Blood (2010) 115 (6): 1113–1120.
https://doi.org/10.1182/blood-2009-05-222539
Published: 2010
Journal Articles

Increased Expression Level of Noxa in Peripheral Versus Lymph Node Chronic Lymphocytic Leukemia Cells Is Correlated with Survival Capacity.

Delfine Y.H. Hallaert, Laura A. Smit, Rene Spijker, Bart de Goeij, Annelieke Jaspers, Arnon P. Kater, MD, PhD, Marinus H. van Oers, MD, PhD, Carel J.M. van Noesel, MD, PhD, Eric Eldering, PhD
Journal: Blood
Blood (2006) 108 (11): 4972.
https://doi.org/10.1182/blood.V108.11.4972.4972
Published: 2006